CD44 and cancer: We further quantified the score of the angiogenesis pathway in CD44+ TAMs from each cancer subtype and observed significantly increased activity in CD44+ TAMs from EPN and AEP compared with that in CD44+ TAMs from SE (Fig. 5g), suggesting the stronger pro-tumorigenic properties of CD44+ TAMs in EPN and AEP.